metoclopramide has been researched along with Abdominal Obesity in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Excerpt | Relevance | Reference |
---|---|---|
" Long-term use of various drugs and increased risk of diverse side effects is an unavoidable reality in this population of patients." | 1.51 | Factors Associated with Insulin Resistance in Women with Migraine: A Cross-Sectional Study. ( Gur-Ozmen, S; Karahan-Ozcan, R, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gur-Ozmen, S | 1 |
Karahan-Ozcan, R | 1 |
1 other study available for metoclopramide and Abdominal Obesity
Article | Year |
---|---|
Factors Associated with Insulin Resistance in Women with Migraine: A Cross-Sectional Study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Blood Pressure; Body Composition; Bod | 2019 |